1. Zheng Q#, Lu W#, Yan H#, Duan X#, Chen Y, Zhang C, Luo X, Chen J, Wang C, Liu S, Li Y, Tang
H, Rahimi S, Rahimi S, Yuan JX, Zhong N, Yang K*, Wang J*. Established pulmonary hypertension in rats
was reversed by a combination of a HIF-2 α antagonist and a p53 agonist. Br J Pharmacol. 2022
Mar;179(5):1065-1081. (IF: 9.473,并列通讯)
2. Chen J#, Miao J#, Zhou D#, Liao J#, Wang Z#, Lin Z, Zhang C, Luo X, Li Y, Li X, Liu S, Xing Y,
Zhang Z, Zhao M, Parmisano S, Chen Y, Yuan JX, Yang K*, Sun D*, Wang J*. Upregulation of
Mechanosensitive Channel Piezo1 Involved in High Shear Stress-induced Pulmonary Hypertension.
Thrombosis Research. 2022;218:52-63. (IF: 10.407,并列通讯)
3. Liao J#, Lu W#, Chen Y#, Duan X#, Zhang C, Luo X, Lin Z, Chen J, Liu S, Yan H, Chen Y, Feng H,
Zhou D, Chen X, Zhang Z, Yang Q, Liu X, Tang H, Li J, Makino A, Yuan JX, Zhong N, Yang K*, Wang J*.
Upregulation of Piezo1 Enhances the Intracellular Free Calcium in Pulmonary Arterial Smooth Muscle Cells
from Idiopathic Pulmonary Arterial Hypertension Patients. Hypertension. 2021 Jun;77(6):1974-1989. (IF:
9.897,并列通讯)
4. Zhang C#, Lu W#, Luo X#, Liu S, Li Y, Zheng Q, Liu W, Wu X, Chen Y, Jiang Q, Zhang Z, Gu G,
Chen J, Chen H, Liao J, Liu C, Hong C, Tang H, Sun D, Yang K*, Wang J*. Mitomycin C Induces
Pulmonary Vascular Endothelial-to-mesenchymal Transition and Pulmonary Veno-occlusive Disease via
Smad3-dependent Pathway in Rats. Br J Pharmacol. 2021 Jan;178(1):217-235. (IF: 9.473,并列通讯)
5. Jiang Q#, Liu C#, Liu S#, Lu W#, Li Y, Luo X, Ma R, Zhang C, Chen H, Chen Y, Zhang Z, Hong C,
Guo W, Wang T, Yang K*, Wang J*. Dysregulation of BMP9/BMPR2/SMAD Signaling Pathway
Contributes to the Bleomycin-induced Pulmonary Fibrosis and Pulmonary Hypertension in a Rat Model. Br J
Pharmacol. 2021 Jan;178(1):203-216. (IF: 9.473,并列通讯)
6. Zhang C#, Zhang T#, Lu W#, Duan X#, Luo X, Liu S, Chen Y, Li Y, Chen J, Liao J, Zhou D, Chen
X, Feng H, Gu G, Wang T, Tang H, Makino A, Zhong N, Yuan JX, Yang K*, Wang J*. Altered Airway
Microbiota Composition in Patients with Pulmonary Hypertension. Hypertension. 2020
Nov;76(5):1589-1599. (Hypertension Editors’ Picks: Pulmonary Hypertension) (IF: 9.897,并列通讯)
7. Chen J#, Zhou D#, Miao J#, Zhang C#, Li X#, Feng H, Xing Y, Zhang Z, Bao C, Lin Z, Chen Y,
Yuan JX, Sun D, Yang K*, Wang J*. Microbiome and metabolome dysbiosis of the gut-lung axis in
pulmonary hypertension. Microbiological Research. 2022. In press. (IF: 5.07,并列通讯)
8. Wang J#, Liu W#, Lu W#, Luo X#, Lin Y#, Liu S, Qian J, Zhang C, Chen H, Li Y, Li, X, Chen J,
Chen Y, Jiang Q, Liu C, Hong C, Wang T, Tang H, Zhong N, Yang J*, Yang K*, Sun D*. Sodium
Tanshinone IIA Sulfonate Enhances the BMP9-BMPR2-Smad1/5/9 Signaling Pathway in Rat Pulmonary
Microvascular Endothelial Cells and Human Embryonic Stem Cell – derived Endothelial Cells. Biochem
Pharmacol. 2022 May;199:114986. (IF: 6.1,并列通讯)
9. Luo C#, Wu W#, Lou S, Zhao S, Yang K*. Improving the in vivo bioavailability and in vitro
anti-inflammatory activity of tanshinone IIA by alginate solid dispersion. J Drug Deliv Sci Tec.
2020;(60):101966. (IF: 5.062,独立通讯)